The U.S. Food and Drug Administration (FDA) recently approved ruxolitinib, the first drug for patients with acute graft-versus-host disease (GVHD) who have an inadequate response to steroid treatment. VUMC's Madan Jagasia, MBBS, MS, MMHC, was a lead investigator of the REACH1 trial that was the basis for the FDA approval.

Cathy Maxwell, PhD, Shelagh Mulvaney, PhD, and Bethany Rhoten, PhD, have been named Vanderbilt University School of Nursing’s first Valere Potter Distinguished Dean’s Faculty Fellows.

Kelly Brown, MD, associate professor of Clinical Neurology, will be assuming the role of executive medical director of the Neurosciences Patient Care Center (PCC) effective July 1.

Todd Peterson, PhD, associate professor of Radiology and Radiological Sciences, has been appointed director of the Vanderbilt University Institute of Imaging Science (VUIIS) Radiochemistry Core Lab, following the departure of Michael Nickels, PhD.

Have you ever wondered how Vanderbilt University School of Medicine recruits each year an outstanding class of future physician leaders and scientists? It is truly a team effort

Rick W. Wright, MD, one of the nation’s leading orthopaedic surgeons and sports medicine specialists, has been named chair of the Department of Orthopaedic Surgery at Vanderbilt University Medical Center. He will join the faculty Sept. 1.